Found 69 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

16 years - 75 years
All genders
Phase 2
Interventional
This study investigates primary focal segmental glomerulosclerosis and minimal change disease. The purpose of this study is to explore these conditions in participants aged 16 to 75 years.This study evaluates the safety and effectiveness of investigational medications compared to a placebo. It will focus on understanding changes in protein levels …
18 years or above
All genders
Phase 1
Interventional
This study investigates the condition of relapsed/refractory myeloma. It focuses on understanding more about this condition through the use of an investigational medication.The purpose of this study is to evaluate the safety and effectiveness of the investigational medication. It looks at how well participants tolerate the medication and its overall …
18 years or above
Accepts healthy volunteer
Male
Phase 3
This study investigates the use of tadalafil for erectile dysfunction. The purpose of this study is to see if participants can choose and use tadalafil appropriately based on product labeling and a health survey.The study evaluates how well participants can follow instructions for using tadalafil safely and effectively. It looks …
10 years - 55 years
All genders
Phase 1/2
Interventional
This study investigates non-congenital myotonic dystrophy type 1. The purpose of this study is to explore how an investigational gene therapy affects this condition.The study evaluates the safety and effectiveness of the gene therapy. It looks at how well the therapy works in reducing certain protein levels and improving muscle …
10 years - 65 years
All genders
Phase 3
Interventional
This study investigates sickle-cell disease. It focuses on understanding the effects of an investigational medication on people with this condition.The study evaluates the safety and effectiveness of the investigational medication. Researchers are interested in how well participants tolerate the treatment.Who can participate: Participants aged 10 to 65 years with sickle-cell …
12 years or above
All genders
Phase 4
Interventional
This study investigates synovial hypertrophy in individuals with hemophilia A.The study evaluates the effects of a weekly dose of investigational medication over a 12-month period. It focuses on assessing changes in joint conditions related to synovial hypertrophy.Who can participate: Participants must be 12 years or older with moderate to severe …
18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of different doses of an investigational medication compared to a placebo for Crohn's disease.The purpose of this study is to understand the safety and effectiveness of the investigational medication for people with Crohn's disease.Who can participate: Adults with moderate to severe Crohn's disease, who have …
18 years or above
All genders
Phase 3
Interventional
This study investigates immune thrombocytopenia (ITP).The study evaluates the safety and effectiveness of an oral investigational medication in adults with ITP who did not respond to first-line treatment.Who can participate: Adults aged 18 and older with a history of primary immune thrombocytopenia who have failed first-line treatment can participate.Study details: …
1 year - 18 years
All genders
Phase 2
Interventional
This study investigates chronic graft versus host disease (cGVHD) in children. The purpose of this study is to learn more about cGVHD in participants aged 1 to less than 18 years.The study evaluates the safety and effectiveness of the investigational medication in children with cGVHD. It focuses on understanding how …
16 years - 80 years
All genders
Phase 3
Interventional
This study focuses on participants with moderately to severely active Crohn's disease.The study evaluates the effectiveness and safety of an investigational medication. This study investigates how well the medication works and how safe it is for people with Crohn's disease.Who can participate: Participants aged 18 to 80 years, and those …